Subscribe
shutterstock_1086968018_jarretera
jarretera / Shutterstock.com
5 April 2019Americas

FDA boosts customs collaboration to fight fake drugs

The  US Food and Drug Administration (FDA) and  US Customs and Border Protection (CBP) have strengthened their collaboration in a bid to halt the import of counterfeit drugs and protect public health.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
FDA warns stem cell company over unapproved treatments
4 June 2019   The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.
Americas
Arizona man sentenced to prison for trafficking counterfeit drugs
8 February 2017   An Arizona-based man was sentenced to more than three years in federal prison for trafficking counterfeit pet pharmaceutical products into the US.


Editor's picks

Why US patent reform is ‘essential’ for US economic prosperity and security
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025

Editor's picks

Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025
Americas
Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
3 April 2025
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025

More on this story

Big Pharma
FDA warns stem cell company over unapproved treatments
4 June 2019   The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.
Americas
Arizona man sentenced to prison for trafficking counterfeit drugs
8 February 2017   An Arizona-based man was sentenced to more than three years in federal prison for trafficking counterfeit pet pharmaceutical products into the US.

More on this story

Big Pharma
FDA warns stem cell company over unapproved treatments
4 June 2019   The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.
Americas
Arizona man sentenced to prison for trafficking counterfeit drugs
8 February 2017   An Arizona-based man was sentenced to more than three years in federal prison for trafficking counterfeit pet pharmaceutical products into the US.

More features

UPC orders 17-country ban on EOFlow's pumps in Insulet feud
US warns of rising counterfeit drug threat from India and China
Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit
Biotech and healthcare expert returns to Latham & Watkins
AstraZeneca to appeal invalidated diabetes patent in generics dispute
Why US patent reform is ‘essential’ for US economic prosperity and security
Medical company sees $452m trade secrets award cut by 87%
Fed Circ: Generic doesn’t infringe Metacel MS drug